{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T05:43:35Z","timestamp":1778391815461,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2012,8,1]]},"DOI":"10.2174\/187152412802430156","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T19:39:38Z","timestamp":1345491578000},"page":"233-239","source":"Crossref","is-referenced-by-count":25,"title":["The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System"],"prefix":"10.2174","volume":"12","author":[{"given":"John","family":"C. Ashton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/101633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:42:44Z","timestamp":1448289764000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5249&volume=12&issue=3&spage=233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187152412802430156","relation":{},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,1]]}}}